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Market Report
Livestock and Products,
Weekly Average
Nebraska Slaughter Steers,
35-65% Choice, Live Weight. . . . . . .
Nebraska Feeder Steers,
Med. & Large Frame, 550-600 lb. . . . .
Nebraska Feeder Steers,
Med. & Large Frame 750-800 lb. . .. .
Choice Boxed Beef,
600-750 lb. Carcass. . . . . . . . . . . . . .
Western Corn Belt Base Hog Price
Carcass, Negotiated . . . . . . . . . . . . . ..
Pork Carcass Cutout, 185 lb. Carcass
51-52% Lean. . . . . . . . . . . . . . . . . . . .
Slaughter Lambs, wooled and shorn,
135-165 lb. National. . . . . . .
National Carcass Lamb Cutout
FOB. . . . . . . . . . . . . . . . . . . . . . . . . . .
Crops,
Daily Spot Prices
Wheat, No. 1, H.W.
Imperial, bu. . . . . . . . . . . . . . . . . . . . .
Corn, No. 2, Yellow
Nebraska City, bu. . . . . . . . . . . . . . . .
Soybeans, No. 1, Yellow
Nebraska City, bu. . . . . . . . . . . . . .. . .
Grain Sorghum, No.2, Yellow
Dorchester, cwt. . . . . . . . . . . . . . . . . .
Oats, No. 2, Heavy
Minneapolis, Mn, bu. . . . . . . . . . . . . . .
Feed
Alfalfa, Large Square Bales,
Good to Premium, RFV 160-185
Northeast Nebraska, ton. . . . . . . . . . .
Alfalfa, Large Rounds, Good
Platte Valley, ton. . . . . . . . . . . . . . . . .
Grass Hay, Large Rounds, Good
Nebraska, ton. . . . . . . . . . . . . . .. . . .
Dried Distillers Grains, 10% Moisture
Nebraska Average. . . . . . . . . . . . . . . .
Wet Distillers Grains, 65-70% Moisture
Nebraska Average. . . . . . . . . . . . . . . .
⃰ No Market
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138.14

100.21

104.04

220.29

143.09

133.80

200.83

141.27
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219.22

186.63

182.00

60.77

48.53

44.87

81.94

75.24

72.64

156.73

158.36

146.03

357.69

353.14
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The 2016 World Food Prize was awarded in October to four scientists for their pioneering work
on bio-fortification — a process of enhancing
traditional foods with micronutrients, particularly vitamins and minerals, through conventional selective breeding or genetic engineering.
Three of the laureates who work in African
countries bred and championed the orangefleshed sweet potatoes1. Although not native to
the African continent, the orange-fleshed sweet
potato is enhanced with beta-carotene to boost
vitamin A content and combat vitamin A deficiency, a health challenge in many developing
countries.
Despite their potential role in combating malnutrition and hunger, the introduction of genetically modified (GM) foods has been strongly
contested since their commercialization in 1996.
Attitudes toward GM foods have been influenced by whether they confer value to producers
or consumers. While the introduction of first
generation GM foods that conferred agronomic
benefits to producers was initially met with
strong consumer opposition (Giannakas and
Yiannaka 2008), second generation, consumeroriented GM products, which have enhanced
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1 The three laureates who developed the orange fleshed
sweet potato are Drs. Maria Andrade, Jan Low and Robert
Mwanga, all with the International Potato Center. Dr.
Howarth Bouis, the fourth laureate is the founder of HarvestPlus at the International Food Policy Research Institute (IFPRI).
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functional properties (e.g., bio-fortified GM foods),
have been gaining acceptance by consumers (De Steur
et al. 2015). Building on second generation GM foods,
recently developed third generation GM food products
claim to provide health and disease treatment benefits
to consumers. Nutraceuticals, as such products are are
called, are foods or parts of foods that provide medicinal or health benefits to consumers, including the prevention and treatment of diseases (Kalra 2003). Genetically engineered (GE) nutraceuticals thus include
foods associated with increased health benefits and/or
disease prevention (second generation GM food products), but also plants and animal products that could
be used to create vaccines and drugs to treat or cure
diseases (third generation GM products). Examples of
GE nutraceuticals are rice that can be used for a cholera vaccine (Murnaghan 2012), GE bananas that can be
used for a Hepatitis B vaccine (American Chemical
Society 2007), and a GE version of the tobacco plant
that could be used in a vaccine for the human papillomavirus (HPV) or cervical cancer. At present, Astellas
Pharma in Japan is at the forefront of conducting clinical trials for a vaccine in rice against diarrheal diseases
such as cholera (Taylor 2016).
In the United States, the Food and Drug Administration (FDA) regulates nutraceuticals either as a dietary
supplement or a food ingredient depending on how
they are marketed by manufacturers (FDA 2016). The
market for nutraceuticals is growing with an expanding global market valued at $165 billion in 2014 and
projected to attain a staggering $278 billion by 2021
(Transparency Market Research 2016).
A study conducted by researchers in the Department
of Agricultural Economics at the University of Nebraska-Lincoln (UNL) examined public attitudes and purchase intentions for GE nutraceuticals that either offer
general health benefits or a treatment/cure for diseases.
The study also examined how GE nutraceuticals are
perceived with respect to their conventional and organic counterparts. An online survey that elicited responses related to views on GMOs, attitudes towards
food labeling, preferences for genetically engineered
nutraceuticals and demographic information was completed by 1,271 randomly selected students at UNL.
Survey results show that although the majority of respondents view GM food products favorably, they nevertheless express a strong preference for GM labeling.
Faced with a choice between a GE nutraceutical with a

disease treatment benefit and an organic food substitute with no such benefits, both sold at the same
price, nearly half of all respondents indicated they
would choose the GE nutraceutical, a quarter were
indifferent between the two, while a quarter of respondents indicated a preference for the organic
food product. When asked to consider a choice
between a GE nutraceutical that offers general
health benefits and its organic counterpart, both
sold at the same price, respondents were evenly
split with a third preferring the GE nutraceutical
that offered general health benefits, a third were
indifferent between the two, while the remainder
one third preferred the organic food product.
In terms of purchase intentions, over 60% of respondents were equally willing to purchase GE
nutraceuticals that offered treatment for diseases,
versus GE nutraceuticals that offered general
health benefits, such as disease prevention. A little
more than a quarter of respondents were, however, more willing to purchase the GE nutraceuticals
with the disease treatment benefit and were willing
to pay an average price premium of 20% more for
such products. Overall, the majority of respondents expressed willingness to purchase GE
nutraceuticals developed to treat an illness, improve health and prevent diseases, as shown in
Figure 1. However, price appeared to be a key determinant—less than a fifth of respondents would
likely purchase GE nutraceuticals if they were
more expensive than their conventional counterparts.
Figure 1. Purchase intention for GE nutraceuticals
with different functionalities

Two methodological approaches were used to analyze
the data. The multinomial logistic regression was used
to analyze unordered dependent variables pertaining to
preferences between GE nutraceuticals that offer general health benefits and treatment for diseases versus
an organic food substitute that does not offer the same
benefits. A tobit model was used to analyze factors that
influenced respondents’ willingness to pay a premium
for GE nutraceuticals that offered treatment for diseases versus one that offered general health benefits, such
as disease prevention. Empirical findings reveal that a
number of respondent characteristics influence their
preference for GE nutraceuticals. Specifically, respondents who paid greater attention to food production
processes were 1.14 times less likely to purchase GE
nutraceuticals that offered general health benefits, and
instead had a 47% increase in their odds of purchasing
an organic food product, relative to being indifferent
between the two products. As expected, acceptance of
the use of genetic modification in food production was
associated with a greater acceptance of GE nutraceuticals. The partial odds of this group purchasing GE
nutraceuticals that offered general health benefits and
treatment against diseases increased by a factor of 1.98
and 1.65 times, respectively. Study results also indicate
price sensitivity among respondents, including those
more accepting of GM foods; not a surprising result
given that our sample consists of college students. In
light of the growing acceptance of bio-fortified GM
foods, the above result suggests that GE nutraceuticals
could further increase consumer acceptance and the
market potential of GM foods.
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